Journal of Clinical Pharmacy and Therapeutics 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Liver injury induced by clomiphene citrate: A case report and literature reviews
Journal of Clinical Pharmacy and Therapeutics,Volume 43, Issue 2, Page 299-301, April 2018. (Source: Journal of Clinical Pharmacy and Therapeutics)
Source: Journal of Clinical Pharmacy and Therapeutics - November 17, 2017 Category: Drugs & Pharmacology Source Type: research
---
Journal of Clinical Pharmacy and Therapeutics, Ahead of Print. (Source: Journal of Clinical Pharmacy and Therapeutics)
Source: Journal of Clinical Pharmacy and Therapeutics - November 17, 2017 Category: Drugs & Pharmacology Source Type: research
---
Journal of Clinical Pharmacy and Therapeutics,Volume 43, Issue 2, Page 299-301, April 2018. (Source: Journal of Clinical Pharmacy and Therapeutics)
Source: Journal of Clinical Pharmacy and Therapeutics - November 17, 2017 Category: Drugs & Pharmacology Source Type: research
Liver injury induced by clomiphene citrate: A case report and literature reviews
We report a case of liver injury which is associated with administration of clomiphene citrate in a male patient.
Case summaryA 31‐year‐old man who was treated by clomiphene citrate for 5 days was transferred to our emergency room with reddish‐brown urine and upper abdominal pain. The levels of aspartate aminotransferase (AST) and alanine aminotransferase (ALT) were elevated. Based on the subsequent examination, he was diagnosed with liver injury and cholecystitis. The levels of AST and ALT returned to normal range after discontinuation of clomiphene citrate and symptomatic treatment.
What is new and conclusionThe m...
Source: Journal of Clinical Pharmacy and Therapeutics - November 17, 2017 Category: Drugs & Pharmacology Authors: H. ‐M. Zhang, X.‐H. Zhao, Y.‐F. He, L.‐R. Sun Tags: CASE REPORT Source Type: research
Validation of a tool for reporting pharmacists' interventions in everyday community pharmacy
This study aimed to develop and validate a tool for the routine reporting of pharmacists' interventions in French community settings.
MethodsTwo groups of community pharmacists coded reports of 60 typical pharmacists' interventions. One group was “experts” (n = 4) who had participated in the development of the tool (internal validation) and the other were “external” community pharmacists (n = 6), naïve to the tool (external validation). The Kappa coefficient was used to assess the inter‐reliability of classification between participants. A 4‐level Likert scale was used to evaluate ease of use and acceptabi...
Source: Journal of Clinical Pharmacy and Therapeutics - November 16, 2017 Category: Drugs & Pharmacology Authors: T. H. Vo, J. ‐D. Bardet, B. Charpiat, C. Leyrissoux, J. Gravoulet, B. Allenet, O. Conort, P. Bedouch Tags: ORIGINAL ARTICLE Source Type: research
Validation of a tool for reporting pharmacists' interventions in everyday community pharmacy
Journal of Clinical Pharmacy and Therapeutics,Volume 43, Issue 2, Page 240-248, April 2018. (Source: Journal of Clinical Pharmacy and Therapeutics)
Source: Journal of Clinical Pharmacy and Therapeutics - November 15, 2017 Category: Drugs & Pharmacology Source Type: research
---
Journal of Clinical Pharmacy and Therapeutics,Volume 43, Issue 2, Page 240-248, April 2018. (Source: Journal of Clinical Pharmacy and Therapeutics)
Source: Journal of Clinical Pharmacy and Therapeutics - November 15, 2017 Category: Drugs & Pharmacology Source Type: research
Risk of tuberculosis comparison in new users of antitumour necrosis factor ‐α and with existing disease‐modifying antirheumatic drug therapy
We examined the incidence of active tuberculosis (TB) and its risk factors in patients with rheumatic disease started with anti‐TNF‐α therapy or with existing disease‐modifying antirheumatic drug (DMARD) therapy.
MethodsA retrospective cohort study of anti‐TNF‐α therapy new users (anti‐TNF‐α group) and those starting with a DMARD after the failure of at least one other DMARD or who had added to existing DMARD treatment (DMARD group) for rheumatic disease in the largest medical setting in Taiwan from 1 January 2005 through 31 November 2013 was conducted to determine relative risk of TB between patient group...
Source: Journal of Clinical Pharmacy and Therapeutics - November 9, 2017 Category: Drugs & Pharmacology Authors: M. ‐J. Chan, Y.‐H. Wen, Y.‐B. Huang, H.‐Y. Chuang, Y.‐L. Tain, Y.‐C. Lily Wang, C.‐N. Hsu Tags: ORIGINAL ARTICLE Source Type: research
Leukotriene receptor antagonism may not be effective in atopic dermatitis treatment after all
ConclusionCurrent literature evidence is limited to rationally support the use of montelukast in atopic dermatitis treatment. For now, the conventional treatments should be preferred in the clinical setting. (Source: Journal of Clinical Pharmacy and Therapeutics)
Source: Journal of Clinical Pharmacy and Therapeutics - November 8, 2017 Category: Drugs & Pharmacology Authors: W. K. Chin Tags: COMMENTARY Source Type: research
Risk of tuberculosis comparison in new users of antitumour necrosis factor ‐α and with existing disease‐modifying antirheumatic drug therapy
Journal of Clinical Pharmacy and Therapeutics,Volume 43, Issue 2, Page 256-264, April 2018. (Source: Journal of Clinical Pharmacy and Therapeutics)
Source: Journal of Clinical Pharmacy and Therapeutics - November 8, 2017 Category: Drugs & Pharmacology Source Type: research
---
Journal of Clinical Pharmacy and Therapeutics,Volume 43, Issue 2, Page 256-264, April 2018. (Source: Journal of Clinical Pharmacy and Therapeutics)
Source: Journal of Clinical Pharmacy and Therapeutics - November 8, 2017 Category: Drugs & Pharmacology Source Type: research
Effects of dopamine receptor antagonist antipsychotic therapy on blood pressure
ConclusionBased upon this review, individuals on antipsychotic agents, particularly clozapine, should be routinely monitored for hypertension, and addition of antihypertensive agents such as angiotensin‐converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) is indicated if hypertension occurs.
Dopamine receptors play a role in blood pressure regulation. The objective of this review is to investigate the association between dopamine antagonist use and hypertension. Based upon this review, individuals on antipsychotic agents, particularly clozapine, should have blood pressure routinely monitored, and a...
Source: Journal of Clinical Pharmacy and Therapeutics - November 8, 2017 Category: Drugs & Pharmacology Authors: N. H. Gonsai, V. H. Amin, C. G. Mendpara, R. Speth, G. M. Hale Tags: REVIEW ARTICLE Source Type: research
Effect of zoledronic acid therapy on postmenopausal osteoporosis between the Uighur and Han population in Xinjiang: An open ‐label, long‐term safety and efficacy study
Journal of Clinical Pharmacy and Therapeutics,Volume 43, Issue 3, Page 336-341, June 2018. (Source: Journal of Clinical Pharmacy and Therapeutics)
Source: Journal of Clinical Pharmacy and Therapeutics - November 7, 2017 Category: Drugs & Pharmacology Authors: W.
Xu
MD, PhD
,
C.
Xiang
MD
,
H.
Wang
MD
,
H.
Yuan
MD
,
X.
Zhao
MD
,
X.
Xiao
MD, PhD Source Type: research
Effect of zoledronic acid therapy on postmenopausal osteoporosis between the Uighur and Han population in Xinjiang: An open ‐label, long‐term safety and efficacy study
Journal of Clinical Pharmacy and Therapeutics, EarlyView. (Source: Journal of Clinical Pharmacy and Therapeutics)
Source: Journal of Clinical Pharmacy and Therapeutics - November 7, 2017 Category: Drugs & Pharmacology Source Type: research
---
Journal of Clinical Pharmacy and Therapeutics, Ahead of Print. (Source: Journal of Clinical Pharmacy and Therapeutics)
Source: Journal of Clinical Pharmacy and Therapeutics - November 7, 2017 Category: Drugs & Pharmacology Source Type: research
